Skip to main content

Persistent Hypothyroidism Despite Levothyroxine Replacement Therapy: Malabsorption or Patient Noncompliance

  • Chapter
  • First Online:
Thyroid and Parathyroid Diseases
  • 1174 Accesses

Abstract

The most important reason for being unable to achieve euthyroidism in the treatment of hypothyroidism is noncompliance with treatment. The state of levothyroxine pseudomalabsorption is a factitious disorder where the patients present with noncompliance with l-thyroxine therapy. In order to diagnose levothyroxine pseudomalabsorption, an l-thyroxine absorption test may be performed. There are different protocols for the test, where 1000–2000 mcg l-thyroxine is given to the patient and blood is withdrawn at 2 h intervals, until up to 24 h. If the free thyroid hormone levels increase during the test, then this suggests that there is no malabsorption. The therapy of levothyroxine pseudomalabsorption may be parenteral infusion at the beginning to achieve an initial euthyroid state and giving the medication orally once or twice a day under medical supervision in the follow-up.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 99.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 129.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 199.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Centanni M. Thyroxine treatment: absorption, malabsorption, and novel therapeutic approaches. Endocrine. 2013;43:8–9.

    Article  CAS  Google Scholar 

  2. Ain KB, Refetoff S, Fein HG, Weintraub BD. Pseudomalabsorption of levothyroxine. JAMA. 1991;266:2118–20.

    Article  CAS  Google Scholar 

  3. Lips DJ, van Reisen MT, Voigt V, Venekamp W. Diagnosis and treatment of levothyroxine pseudomalabsorption. Neth J Med. 2004;62:114–8.

    CAS  PubMed  Google Scholar 

  4. Hays MT. Localization of human thyroxine absorption. Thyroid. 1991;1:241–8.

    Article  CAS  Google Scholar 

  5. Mandel SJ, Brent GA, Larsen PR. Levothyroxine therapy in patients with thyroid disease. Ann Intern Med. 1993;119:492–502.

    Article  CAS  Google Scholar 

  6. Bevan JS, Munro JF. Thyroxine malabsorption following intestinal bypass surgery. Int J Obes. 1986;10:245–6.

    CAS  PubMed  Google Scholar 

  7. Mandel SJ, Larsen PR, Seely EW, Brent GA. Increased need for thyroxine during pregnancy in women with primary hypothyroidism. N Engl J Med. 1990;323:91–6.

    Article  CAS  Google Scholar 

  8. Harmon SM, Seifert CF. Levothyroxine-cholestyramine interaction reemphasized. Ann Intern Med. 1991;115:658–9.

    Article  CAS  Google Scholar 

  9. Leger CS, Ooi TC. Ferrous fumarate-induced malabsorption of thyroxine. Endocrinologist. 1999;9:493–5.

    Article  Google Scholar 

  10. Singh N, Singh PN, Hershman JM. Effect of calcium carbonate on the absorption of levothyroxine. JAMA. 2000;283:2822–5.

    Article  CAS  Google Scholar 

  11. Centanni M, Gargano L, Canettieri G, Viceconti N, Franchi A, Delle Fave G, et al. Thyroxine in goiter, Helicobacter pylori infection, and chronic gastritis. N Engl J Med. 2006;354:1787–95.

    Article  CAS  Google Scholar 

  12. Bach-Huynh TG, Nayak B, Loh J, Soldin S, Jonklaas J. Timing of levothyroxine administration affects serum thyrotropin concentration. J Clin Endocrinol Metab. 2009;94:3905–12.

    Article  CAS  Google Scholar 

  13. Surks MI, Sievert R. Drugs and thyroid function. N Engl J Med. 1995;333:1688–94.

    Article  CAS  Google Scholar 

  14. Ogawa D, Otsuka F, Mimura Y, Ueno A, Hashimoto H, Kishida M, et al. Pseudomalabsorption of levothyroxine: a case report. Endocr J. 2000;47:45–50.

    Article  CAS  Google Scholar 

  15. Payer J, Sladekova K, Kinova S, Cesnakova Z, Killinger Z, Krizko M, et al. Autoimmune thyroiditis with severe hypothyroidism resistant to the treatment with high peroral doses of thyroxine: case report. Endocr Regul. 2000;34:189–93.

    CAS  PubMed  Google Scholar 

  16. Balla M, Jhingan RM, Rubin DJ. Rapid levothyroxine absorption testing: a case series of nonadherent patients. Int J Endocrinol Metab. 2015;13:e31051.

    Article  Google Scholar 

  17. Jauk B, Mikosch P, Gallowitsch HJ, Kresnik E, Molnar M, Gomez I, et al. Unusual malabsorption of levothyroxine. Thyroid. 2000;10:93–5.

    Article  CAS  Google Scholar 

  18. Santaguida MG, Virili C, Del Duca SC, Cellini M, Gatto I, Brusca N, et al. Thyroxine soft gel capsule in patients with gastric-related T4 malabsorption. Endocrine. 2015;49:51–7.

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2019 Springer International Publishing AG, part of Springer Nature

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Yazıcı, D. (2019). Persistent Hypothyroidism Despite Levothyroxine Replacement Therapy: Malabsorption or Patient Noncompliance. In: Özülker, T., Adaş, M., Günay, S. (eds) Thyroid and Parathyroid Diseases. Springer, Cham. https://doi.org/10.1007/978-3-319-78476-2_23

Download citation

  • DOI: https://doi.org/10.1007/978-3-319-78476-2_23

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-319-78475-5

  • Online ISBN: 978-3-319-78476-2

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics